Genetic Syndromes in Pediatrics

Genetic syndromes in pediatrics represent a diverse group of hereditary conditions resulting from chromosomal abnormalities, single-gene mutations, or complex multifactorial inheritance patterns that manifest during childhood with variable phenotypic expression. These disorders collectively affect approximately 2-3% of live births and account for significant pediatric morbidity and mortality, making them essential to recognize for early intervention and family counseling. The clinical importance of genetic syndromes extends beyond individual patient care to include genetic counseling, reproductive planning, and identification of family members at risk—each requiring accurate diagnosis and understanding of inheritance patterns. Recognition of characteristic syndromic features (dysmorphic facies, growth abnormalities, developmental delay, organ-specific malformations) often provides diagnostic clues that enable timely confirmation through molecular or chromosomal testing. Board examinations and clinical practice frequently test knowledge of classic genetic syndromes, their diagnostic criteria, associated complications, and appropriate screening protocols. This comprehensive reference covers the major categories of genetic syndromes, their underlying genetic mechanisms, clinical presentations, diagnostic approaches, and management strategies essential for pediatric practitioners.

The pathophysiologic mechanisms underlying genetic syndromes vary widely depending on the type of genetic abnormality and affected molecular pathways:

Numerical or structural chromosomal abnormalities (trisomies, monosomies, deletions, duplications, translocations) result in altered gene dosage—either overexpression or haploinsufficiency—that disrupts normal developmental programs and organ system formation. In trisomy 21 (Down syndrome), the presence of an extra chromosome 21 creates a 50% gene dosage imbalance across ~300 genes, including genes involved in neuronal development, cardiac morphogenesis, and immune function. This excess gene product disrupts developmental timing and increases risk of congenital heart disease, intellectual disability, and immune dysfunction. Conversely, monosomic conditions (such as Turner syndrome, 45,X) result in loss of critical genes required for ovarian development, growth factor signaling, and normal cardiac development. Segmental chromosomal imbalances from deletions (22q11.2 deletion in DiGeorge syndrome) or duplications (7q11.23 duplication in Williams syndrome) create haploinsufficiency or triplosensitivity effects specific to genes in those regions, producing distinctive phenotypes based on which genes are affected.

Autosomal dominant conditions arise from gain-of-function mutations (producing abnormal, overactive proteins) or dominant-negative mutations (producing proteins that interfere with wild-type function) that disrupt protein structure or enzymatic activity. Achondroplasia, the most common skeletal dysplasia, results from activating FGFR3 mutations causing constitutive activation of fibroblast growth factor signaling, leading to abnormal endochondral ossification and characteristically short stature with specific skeletal features. Autosomal recessive conditions typically involve loss-of-function mutations requiring homozygous or compound heterozygous mutations; two defective alleles reduce or eliminate protein function below critical thresholds. In cystic fibrosis, mutations in the CFTR gene impair cAMP-regulated chloride channel function in epithelial cells, causing viscous secretion accumulation in lungs, pancreas, and biliary ducts. X-linked recessive conditions predominantly affect males with hemizygous mutations, while females may be carriers or exhibit mild disease depending on X-inactivation patterns. Mutations in genes encoding developmental transcription factors (PAX6 in aniridia, SOX9 in campomelic dysplasia) produce widespread developmental abnormalities affecting multiple systems.

Many genetic syndromes result from enzymatic deficiencies disrupting essential metabolic pathways, with accumulation of substrates, depletion of products, or both. Phenylketonuria (PKU) results from deficient phenylalanine hydroxylase activity, causing accumulation of phenylalanine and its metabolites (phenylpyruvate, phenyllactate) that damage developing brain tissue through unknown mechanisms (possibly competitive inhibition of neutral amino acid transporters, oxidative stress, or altered neurotransmitter synthesis). Lysosomal storage diseases (mucopolysaccharidoses, sphingolipidoses) accumulate undegraded macromolecules in lysosomes of multiple tissues, progressively impairing cellular function—in Hurler syndrome (MPS IH), deficient α-L-iduronidase causes accumulation of dermatan and heparan sulfate, leading to hepatosplenomegaly, progressive skeletal dysostosis, developmental delay, and cardiovascular involvement. Mitochondrial disorders (resulting from mitochondrial DNA mutations or nuclear-encoded mitochondrial protein defects) impair oxidative phosphorylation and ATP production, predominantly affecting high-energy-demand tissues (brain, muscle, heart, retina).

Genetic syndromes often involve disruption of developmental signaling pathways controlling embryonic patterning, cell migration, or differentiation. The sonic hedgehog (SHH) pathway disruption in holoprosencephaly (associated with mutations in SHH, ZIC2, SIX3, TGIF, and other genes) prevents midline cleavage of the developing forebrain, causing hypotelorism, cleft palate, microcephaly, and intellectual disability. WNT/β-catenin signaling disruption and PAX gene mutations (controlling transcription of developmental genes) produce various limb, renal, and ocular abnormalities. TGF-β superfamily signaling defects (Marfan syndrome from FBN1 mutations; Ehlers-Danlos syndrome from collagen gene mutations) impair extracellular matrix formation and connective tissue integrity, affecting skeletal, ocular, and cardiovascular systems. The DiGeorge syndrome (22q11.2 deletion) disrupts development of structures derived from the 3rd and 4th pharyngeal pouches due to haploinsufficiency of TBX1 and other genes, producing thymic hypoplasia, parathyroid hypoplasia, cardiac outflow tract defects, and cleft palate.

Genomic imprinting disorders (Prader-Willi syndrome, Angelman syndrome) result from abnormal methylation patterns or deletions affecting imprinted chromosomal regions where parent-of-origin expression is critical. In Prader-Willi syndrome, loss of paternal 15q11-13 expression (via deletion, maternal uniparental disomy, or imprinting defects) removes paternally expressed genes required for normal appetite regulation and muscle development, causing neonatal hypotonia, feeding difficulties, hypogonadism, and later-childhood-onset hyperphagia with obesity. Angelman syndrome, involving loss of maternal 15q11-13 expression, produces developmental delay, seizures, happy demeanor, and ataxia through loss of maternally expressed genes including UBE3A (encoding an ubiquitin ligase).

Trisomies (most commonly involving chromosomes 21, 18, 13, and rarely other autosomes) result from nondisjunction during meiosis I or II, with maternal age being the strongest risk factor—trisomy 21 risk increases exponentially from ~1/1500 at maternal age 20 to ~1/100 at maternal age 40 and ~1/30 at maternal age 45. Risk factors for nondisjunction include advanced maternal age, family history of trisomy (particularly if the mother is a balanced translocation carrier), and certain environmental exposures. Monosomy X (Turner syndrome) results from complete or segmental loss of an X chromosome, occurring with overall prevalence of 1/2000-1/2500 live female births; mosaicism (45,X/46,XX) is common and produces variable phenotypes. Structural chromosomal abnormalities (deletions, duplications, balanced translocations) may be inherited from a carrier parent or arise de novo; parental balanced translocations confer ~10-15% recurrence risk depending on which parent is affected and which chromosome segments are involved.

Autosomal dominant inheritance accounts for achondroplasia, Marfan syndrome, Huntington disease (pediatric presentations are rare), familial hypercholesterolemia, and numerous other syndromes; risk factors include affected parent (50% transmission to offspring), advanced paternal age (for new mutations in genes associated with spermatogonial divisions), and gonadal mosaicism (rare but important for genetic counseling). Autosomal recessive inheritance includes cystic fibrosis, sickle cell disease, thalassemia, lysosomal storage diseases, and many metabolic disorders; two carrier parents have 25% risk for affected children, and higher prevalence in populations with founder mutations or consanguinity. X-linked recessive inheritance (hemophilia A and B, Duchenne muscular dystrophy, fragile X syndrome) predominantly affects males; affected males have affected mother or carrier mother, and affected males cannot pass X-linked conditions to sons (all sons receive Y chromosome) but pass carrier status to all daughters.

Recurrent microdeletions and microduplications (detected by chromosomal microarray analysis) account for significant pediatric genetic disease burden. 22q11.2 deletion (DiGeorge/velocardiofacial syndrome) occurs in ~1/4000 live births and commonly arises de novo, though ~25% of cases are inherited; recurrent microdeletions at 7q11.23 (Williams syndrome), 1p36, 4p (Wolf-Hirschhorn syndrome), and 5p (Cri-du-chat syndrome) have characteristic breakpoints due to nonallelic homologous recombination involving segmental duplications.

Conditions including autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), congenital heart disease (in the absence of identified syndromic features), and isolated cleft lip/palate involve multiple genetic loci plus environmental factors, with recurrence risks lower than single-gene conditions but higher than population baseline (typically 3-10% depending on condition and family history).

Maternal transmission of mitochondrial DNA mutations produces variable phenotypes due to heteroplasmy (mixture of mutant and wild-type mtDNA) and random segregation during cell division. Affected mothers transmit mtDNA mutations to all offspring, but severity is unpredictable; affected fathers do not transmit mutations to any offspring. Common pediatric presentations include Leigh syndrome (progressive neurodegeneration), MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes), and MERRF syndrome (myoclonic epilepsy with ragged-red fibers).

The clinical presentation of genetic syndromes varies dramatically depending on the specific syndrome but generally includes combinations of growth abnormalities, dysmorphic features, developmental delay/intellectual disability, organ system malformations, and metabolic derangements:

Short stature is characteristic of chromosomal syndromes (Down syndrome, Turner syndrome), skeletal dysplasias (achondroplasia, thanatophoric dysplasia), intrauterine growth restriction syndromes, and numerous genetic conditions; severity ranges from mild growth retardation to extreme short stature (as in severe achondroplasia with adult heights ~4 feet). Intrauterine growth restriction and failure to thrive characterize many genetic syndromes and metabolic disorders (PKU, lysosomal storage diseases), resulting from inadequate nutrient absorption, increased metabolic demands, or neurologic dysfunction impairing feeding. Overgrowth characterizes Beckwith-Wiedemann syndrome (featuring prenatal overgrowth, macroglossia, organomegaly, and hypoglycemia) and Sotos syndrome (cerebral gigantism with tall stature, advanced bone age, developmental delay, and characteristic facial features).

Distinctive facial characteristics often provide immediate diagnostic clues: characteristic Down syndrome facies includes hypotonia, upward-slanting palpebral fissures, epicanthal folds, depressed nasal bridge, protruding tongue, and low-set ears; Williams syndrome features elfin facies with supravalvular aortic stenosis, stellate iris, full lips, and periorbital fullness; Marfan syndrome presents with long, narrow face, high-arched palate, and lens dislocation (ectopia lentis); achondroplasia features characteristic midface hypoplasia, frontal bossing, and genu varum; Noonan syndrome features short stature, hypertelorism, downslanting palpebral fissures, low-set ears, short neck, and congenital heart disease (particularly pulmonary valve stenosis).

Developmental delays affecting motor, cognitive, language, and adaptive domains characterize many genetic syndromes; severity ranges from mild (IQ 50-70) in Fragile X syndrome (the most common inherited cause of intellectual disability) to severe (IQ <20) in early infantile epileptic encephalopathy disorders. Hypotonia frequently presents in early infancy, particularly in Down syndrome, Prader-Willi syndrome, and mitochondrial disorders, impairing motor milestones and later muscular tone.

Congenital heart disease occurs in ~25% of Down syndrome cases (endocardial cushion defects, atrial septal defect, ventricular septal defect being most common), ~75% of DiGeorge syndrome cases (tetralogy of Fallot, truncus arteriosus, interrupted aortic arch), ~75% of Williams syndrome cases (supravalvular aortic stenosis, peripheral pulmonary stenosis), and Marfan syndrome (aortic root dilatation, mitral valve prolapse). These malformations result from disrupted development of neural crest-derived cardiac tissues and endocardial cushions.

Cleft lip/palate occurs in numerous syndromes including DiGeorge syndrome (~40% of cases), Treacher Collins syndrome, Pierre Robin sequence, and Stickler syndrome, resulting from disrupted midline fusion during embryonic development or micrognathia causing airway obstruction and secondary palatal cleft.

Renal dysplasia, hypoplasia, or dysgenesis occur in many chromosomal and genetic syndromes; Beckwith-Wiedemann syndrome features nephroblastoma (Wilms tumor) risk (~5%), while WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies, mental retardation from 11p13 deletion) features high neoplasia risk (~50%); hypogonadism characterizes Klinefelter syndrome (XXY), Prader-Willi syndrome, and others.

Bone dysplasias produce characteristic radiographic findings: achondroplasia features short limbs with disproportionate shortening of proximal segments (rhizomelic shortening), genu varum, lumbar lordosis, and narrowing of the intervertebral disc spaces; thanatophoric dysplasia (a more severe skeletal dysplasia) features marked rhizomelic shortening incompatible with life; osteogenesis imperfecta features recurrent fractures, osteopenia, blue sclerae, dentinogenesis imperfecta, and progressive deafness; Ellis-van Creveld syndrome features short stature with acromelic shortening (primarily distal segment shortening), polydactyly, nail dysplasia, congenital heart disease (particularly atrial septal defect), and dental abnormalities.

Ectopia lentis (lens dislocation) characterizes Marfan syndrome and homocystinuria; aniridia (iris hypoplasia) associates with WAGR syndrome; cataracts occur in Down syndrome, rubella embryopathy, Lowe syndrome, and metabolic disorders; retinopathy, retinal degeneration, or visual impairment characterize many lysosomal storage diseases and mitochondrial disorders; hypertelorism (widely spaced eyes) occurs in Noonan syndrome, Williams syndrome, and others.

**

Supporting labs: hypergonadotropic hypogonadism (markedly elevated FSH/LH with low estradiol or testosterone) supports Turner and Klinefelter syndromes.

Surveillance is treatment: AAP health supervision guidelines direct echocardiography in every newborn with Down syndrome, periodic TSH, CBC, hearing and vision testing, and screening for celiac symptoms and obstructive sleep apnea; abdominal ultrasound tumor surveillance in Beckwith-Wiedemann/WAGR.

Klinefelter syndrome: azoospermia, gynecomastia with a small absolute increase in male breast cancer risk, osteoporosis, metabolic syndrome, and mediastinal germ cell tumors.

Trisomy 18 and 13: severe cardiac and CNS malformations with central apnea drive very high first-year mortality.